Canine cancer vaccine in development could see wide distribution

02/28/2012 |

Florida-based company Morphogenesis developed a canine lymphoma cell-processing treatment, a process in which tumor cells become a target for the immune system by being labeled with a bacterial protein. Researchers at Morphogenesis are now developing a vaccine from stock cells instead of using a patient's own tumor cells, which could allow the treatment to become widely available.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Chicago, IL
Senior Manager, Compliance
Fremont, CA
Manager, Business Conduct
Foster City, CA
Product Patent Attorney
Foster City, CA
Employment Counsel
Foster City, CA